The Association between High-density Lipoproteins and Periodontitis


Cite item

Full Text

Abstract

:Periodontitis is one of the most typical chronic dental diseases. This inflammatory disease can change various functions of immune cells and impair lipid metabolism through proinflammatory cytokines. High-Density Lipoprotein (HDL) is considered protective of the cardiovascular system. It has anti-thrombotic and anti-inflammatory effects. In this article, we have reviewed the association between periodontitis and HDL. Various studies have demonstrated a reverse relationship between inflammatory cytokines and HDL. HDL contains antioxidative enzymes and proteins, whereas periopathogens impair HDL's antioxidant function. The presence of periodontal bacteria is associated with a low HDL level in patients with periodontitis. Genetic variants in the interleukin- 6 (IL)-6 gene and cytochrome (CYP)1A1 rs1048943 gene polymorphism are associated with HDL levels and periodontal status. Studies showed that HDL levels improve after treatment for periodontitis. On the one hand, periodontal pathogenic bacteria and their metabolites and pro-inflammatory cytokines from periodontal infection can result in various disorders of lipid metabolism and lipid peroxidation. On the other hand, hyperlipidemia and lipid peroxidation stimulate proinflammatory cytokines, resulting in oxidative stress and delayed wound healing, making individuals susceptible to periodontitis.

About the authors

Ailin Ehteshami

Department of Orthodontics, Isfahan University of Medical Sciences

Email: info@benthamscience.net

Farinaz Shirban

Department of Orthodontics, Isfahan University of Medical Sciences

Email: info@benthamscience.net

Mohammad Bagherniya

Nutrition and Food Security Research Center, Isfahan University of Medical Sciences

Author for correspondence.
Email: info@benthamscience.net

Thozhukat Sathyapalan

Academic Diabetes Endocrinology and Metabolism, Hull York Medical School, University of Hull,

Email: info@benthamscience.net

Tannaz Jamialahmadi

Applied Biomedical Research Center, Mashhad University of Medical Sciences

Email: info@benthamscience.net

Amirhossein Sahebkar

Applied Biomedical Research Center,, Mashhad University of Medical Sciences

Author for correspondence.
Email: info@benthamscience.net

References

  1. Zare Javid, A.; Hormoznejad, R.; Yousefimanesh, H.; Zakerkish, M.; Haghighi-zadeh, M.H.; Dehghan, P.; Ravanbakhsh, M. The impact of resveratrol supplementation on blood glucose, insulin, insulin resistance, triglyceride, and periodontal markers in type 2 diabetic patients with chronic periodontitis. Phytother. Res., 2017, 31(1), 108-114. doi: 10.1002/ptr.5737 PMID: 27807887
  2. Kara, A.; Akman, S.; Ozkanlar, S.; Tozoglu, U.; Kalkan, Y.; Canakci, C.F.; Tozoglu, S. Immune modulatory and antioxidant effects of melatonin in experimental periodontitis in rats. Free Radic. Biol. Med., 2013, 55, 21-26. doi: 10.1016/j.freeradbiomed.2012.11.002 PMID: 23146767
  3. Kallio, K.A.E.; Buhlin, K.; Jauhiainen, M.; Keva, R.; Tuomainen, A.M.; Klinge, B.; Gustafsson, A.; Pussinen, P.J. Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients. Innate Immun., 2008, 14(4), 247-253. doi: 10.1177/1753425908095130 PMID: 18669610
  4. Babaei, H.; Forouzandeh, F.; Maghsoumi-Norouzabad, L.; Yousefimanesh, H.A.; Ravanbakhsh, M.; Zare Javid, A. Effects of chicory leaf extract on serum oxidative stress markers, lipid profile and periodontal status in patients with chronic periodontitis. J. Am. Coll. Nutr., 2018, 37(6), 479-486. doi: 10.1080/07315724.2018.1437371 PMID: 29558323
  5. Kang, B.Y.; Choi, Y.K.; Choi, W.H.; Kim, K.T.; Choi, S.S.; Kim, K.; Ha, N.J. Two polymorphisms of lnterleukin-4 gene in Korean adult periodontitis. Arch. Pharm. Res., 2003, 26(6), 482-486. doi: 10.1007/BF02976867 PMID: 12877559
  6. Boutaga, K.; Savelkoul, P.H.M.; Winkel, E.G.; van Winkelhoff, A.J. Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. J. Periodontol., 2007, 78(1), 79-86. doi: 10.1902/jop.2007.060078 PMID: 17199543
  7. Amano, A.; Chen, C.; Honma, K.; Li, C.; Settem, R.P.; Sharma, A. Genetic characteristics and pathogenic mechanisms of periodontal pathogens. Adv. Dent. Res., 2014, 26(1), 15-22. doi: 10.1177/0022034514526237 PMID: 24736700
  8. Beck, J.D.; Offenbacher, S.; Williams, R.; Gibbs, P.; Garcia, R. Periodontitis: A risk factor for coronary heart disease? Ann. Periodontol., 1998, 3(1), 127-141. doi: 10.1902/annals.1998.3.1.127 PMID: 9722697
  9. Tahamtan, S.; Shirban, F.; Bagherniya, M.; Johnston, T.P.; Sahebkar, A. The effects of statins on dental and oral health: A review of preclinical and clinical studies. J. Transl. Med., 2020, 18(1), 155. doi: 10.1186/s12967-020-02326-8 PMID: 32252793
  10. Bozoglan, A.; Ertugrul, A.S.; Taspınar, M.; Yuzbasioglu, B. Determining the relationship between atherosclerosis and periodontopathogenic microorganisms in chronic periodontitis patients. Acta Odontol. Scand., 2017, 75(4), 233-242. doi: 10.1080/00016357.2017.1280739 PMID: 28116969
  11. Choi, Y.H.; Kosaka, T.; Ojima, M.; Sekine, S.; Kokubo, Y.; Watanabe, M.; Miyamoto, Y.; Ono, T.; Amano, A. Relationship between the burden of major periodontal bacteria and serum lipid profile in a cross-sectional Japanese study. BMC Oral Health, 2018, 18(1), 77. doi: 10.1186/s12903-018-0536-0 PMID: 29728099
  12. Pussinen, P.J.; Jousilahti, P.; Alfthan, G.; Palosuo, T.; Asikainen, S.; Salomaa, V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler. Thromb. Vasc. Biol., 2003, 23(7), 1250-1254. doi: 10.1161/01.ATV.0000072969.71452.87 PMID: 12714435
  13. Scannapieco, F.A.; Bush, R.B.; Paju, S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann. Periodontol., 2003, 8(1), 38-53. doi: 10.1902/annals.2003.8.1.38 PMID: 14971247
  14. Kozarov, E.V.; Dorn, B.R.; Shelburne, C.E.; Dunn, W.A., Jr; Progulske-Fox, A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol., 2005, 25(3), e17-e18. doi: 10.1161/01.ATV.0000155018.67835.1a PMID: 15662025
  15. Schenkein, H.A.; Loos, B.G. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J. Periodontol., 2013, 84(4), S51-S69. PMID: 23631584
  16. Offenbacher, S.; Elter, J.R.; Lin, D.; Beck, J.D. Evidence for periodontitis as a tertiary vascular infection. J. Int. Acad. Periodontol., 2005, 7(2), 39-48. PMID: 15912923
  17. Gordon, D.J.; Probstfield, J.L.; Garrison, R.J.; Neaton, J.D.; Castelli, W.P.; Knoke, J.D.; Jacobs, D.R., Jr; Bangdiwala, S.; Tyroler, H.A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation, 1989, 79(1), 8-15. doi: 10.1161/01.CIR.79.1.8 PMID: 2642759
  18. Sharrett, A.R.; Ballantyne, C.M.; Coady, S.A.; Heiss, G.; Sorlie, P.D.; Catellier, D.; Patsch, W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 2001, 104(10), 1108-1113. doi: 10.1161/hc3501.095214 PMID: 11535564
  19. Bacchetti, T.; Ferretti, G.; Carbone, F.; Ministrini, S.; Montecucco, F.; Jamialahmadi, T.; Sahebkar, A. Dysfunctional high-density lipoprotein: The role of myeloperoxidase and paraoxonase-1. Curr. Med. Chem., 2021, 28(14), 2842-2850. doi: 10.2174/1875533XMTA43MjAgw PMID: 32674726
  20. Bahrami, A.; Barreto, G.E.; Lombardi, G.; Pirro, M.; Sahebkar, A. Emerging roles for high-density lipoproteins in neurodegenerative disorders. Biofactors, 2019, 45(5), 725-739. doi: 10.1002/biof.1541 PMID: 31301192
  21. Ganjali, S.; Dallinga-Thie, G.M.; Simental-Mendía, L.E.; Banach, M.; Pirro, M.; Sahebkar, A. HDL functionality in type 1 diabetes. Atherosclerosis, 2017, 267, 99-109. doi: 10.1016/j.atherosclerosis.2017.10.018 PMID: 29102899
  22. Ganjali, S.; Gotto, A.M., Jr; Ruscica, M.; Atkin, S.L.; Butler, A.E.; Banach, M.; Sahebkar, A. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J. Cell. Physiol., 2018, 233(12), 9237-9246. doi: 10.1002/jcp.27028 PMID: 30076716
  23. Ganjali, S.; Hosseini, S.; Rizzo, M.; Kontush, A.; Sahebkar, A. Capacity of HDL to efflux cellular cholesterol from lipid-loaded macrophages is reduced in patients with familial hypercholesterolemia. Metabolites, 2023, 13(2), 197. doi: 10.3390/metabo13020197 PMID: 36837816
  24. Ganjali, S.; Momtazi, A.A.; Banach, M.; Kovanen, P.T.; Stein, E.A.; Sahebkar, A. HDL abnormalities in familial hypercholesterolemia: Focus on biological functions. Prog. Lipid Res., 2017, 67, 16-26. doi: 10.1016/j.plipres.2017.05.001 PMID: 28506805
  25. Ganjali, S.; Ricciuti, B.; Pirro, M.; Butler, A.E.; Atkin, S.L.; Banach, M.; Sahebkar, A. High-density lipoprotein components and functionality in cancer: State-of-the-art. Trends Endocrinol. Metab., 2019, 30(1), 12-24. doi: 10.1016/j.tem.2018.10.004 PMID: 30473465
  26. Ganjali, S.; Shirmohammadi, L.; Read, M.I.; Sahebkar, A. High-density lipoprotein functionality in systemic lupus erythematosus. Semin. Arthritis Rheum., 2020, 50(4), 769-775. doi: 10.1016/j.semarthrit.2020.05.011 PMID: 32531506
  27. Bagherniya, M.; Sahebkar, A.; Sadeghalbanaei, L.; Shirban, F.; Sathyapalan, T. The role of high-density lipoprotein in oral and dental diseases. Curr. Med. Chem., 2023, 30(20), 2226-2246. doi: 10.2174/0929867329666220901120654 PMID: 36056865
  28. Yazdandoust, S.; Parizadeh, S.M.R.; Ghayour-Mobarhan, M.; Yaghmaei, P.; Sahebkar, A.H. High-density lipoprotein lipid peroxidation as a diagnostics biomarker in coronary artery disease. Biofactors, 2022, 48(3), 634-642. doi: 10.1002/biof.1819 PMID: 35080064
  29. Di Angelantonio, E.; Sarwar, N.; Perry, P.; Kaptoge, S.; Ray, K.K.; Thompson, A.; Wood, A.M.; Lewington, S.; Sattar, N.; Packard, C.J.; Collins, R.; Thompson, S.G.; Danesh, J. Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 2009, 302(18), 1993-2000. doi: 10.1001/jama.2009.1619 PMID: 19903920
  30. Kim, H.J.; Cha, G.S.; Kim, H.J.; Kwon, E.Y.; Lee, J.Y.; Choi, J.; Joo, J.Y. Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein. J. Periodontal Implant Sci., 2018, 48(1), 60-68. doi: 10.5051/jpis.2018.48.1.60 PMID: 29535891
  31. O’Neill, F.; Riwanto, M.; Charakida, M.; Colin, S.; Manz, J.; McLoughlin, E.; Khan, T.; Klein, N.; Kay, C.W.M.; Patel, K.; Chinetti, G.; Staels, B.; D’Aiuto, F.; Landmesser, U.; Deanfield, J. Structural and functional changes in HDL with low grade and chronic inflammation. Int. J. Cardiol., 2015, 188, 111-116. doi: 10.1016/j.ijcard.2015.03.058 PMID: 25919891
  32. Rosenson, R.S.; Brewer, H.B., Jr; Ansell, B.J.; Barter, P.; Chapman, M.J.; Heinecke, J.W.; Kontush, A.; Tall, A.R.; Webb, N.R. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat. Rev. Cardiol., 2016, 13(1), 48-60. doi: 10.1038/nrcardio.2015.124 PMID: 26323267
  33. Mineo, C.; Shaul, P.W. Novel biological functions of high-density lipoprotein cholesterol. Circ. Res., 2012, 111(8), 1079-1090. doi: 10.1161/CIRCRESAHA.111.258673 PMID: 23023510
  34. Norata, G.D.; Pirillo, A.; Ammirati, E.; Catapano, A.L. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis, 2012, 220(1), 11-21. doi: 10.1016/j.atherosclerosis.2011.06.045 PMID: 21783193
  35. Patel, S.; Di Bartolo, B.A.; Nakhla, S.; Heather, A.K.; Mitchell, T.W.; Jessup, W.; Celermajer, D.S.; Barter, P.J.; Rye, K.A. Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis, 2010, 212(2), 392-397. doi: 10.1016/j.atherosclerosis.2010.05.035 PMID: 20609437
  36. Li, Y.; Dong, J.B.; Wu, M.P. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur. J. Pharmacol., 2008, 590(1-3), 417-422. doi: 10.1016/j.ejphar.2008.06.047 PMID: 18593575
  37. Kameda, T.; Ohkawa, R.; Yano, K.; Usami, Y.; Miyazaki, A.; Matsuda, K.; Kawasaki, K.; Sugano, M.; Kubota, T.; Tozuka, M. Effects of myeloperoxidase-induced oxidation on antiatherogenic functions of high-density lipoprotein. J. Lipids, 2015, 2015, 592594. doi: 10.1155/2015/592594 PMID: 26257958
  38. Papageorgiou, N.; Tousoulis, D. Interaction between HDL and inflammation: When the good turns to be bad. Int. J. Cardiol., 2015, 189, 15-17. doi: 10.1016/j.ijcard.2015.03.411 PMID: 25885867
  39. Pussinen, P.J.; Tuomisto, K.; Jousilahti, P.; Havulinna, A.S.; Sundvall, J.; Salomaa, V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler. Thromb. Vasc. Biol., 2007, 27(6), 1433-1439. doi: 10.1161/ATVBAHA.106.138743 PMID: 17363692
  40. Levine, D.M.; Parker, T.S.; Donnelly, T.M.; Walsh, A.; Rubin, A.L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci., 1993, 90(24), 12040-12044. doi: 10.1073/pnas.90.24.12040 PMID: 8265667
  41. Goteiner, D.; Craig, R.G.; Ashmen, R.; Janal, M.N.; Eskin, B.; Lehrman, N. Endotoxin levels are associated with high-density lipoprotein, triglycerides, and troponin in patients with acute coronary syndrome and angina: Possible contributions from periodontal sources. J. Periodontol., 2008, 79(12), 2331-2339. doi: 10.1902/jop.2008.080068 PMID: 19053924
  42. Baranova, I.; Vishnyakova, T.; Bocharov, A.; Chen, Z.; Remaley, A.T.; Stonik, J.; Eggerman, T.L.; Patterson, A.P. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect. Immun., 2002, 70(6), 2995-3003. doi: 10.1128/IAI.70.6.2995-3003.2002 PMID: 12010990
  43. Pussinen, P.J.; Jauhiainen, M.; Vilkuna-Rautiainen, T.; Sundvall, J.; Vesanen, M.; Mattila, K.; Palosuo, T.; Alfthan, G.; Asikainen, S. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J. Lipid Res., 2004, 45(1), 139-147. doi: 10.1194/jlr.M300250-JLR200 PMID: 13130123
  44. Soumyarani, V.S.; Jayakumari, N. Oxidatively modified high density lipoprotein promotes inflammatory response in human monocytes–macrophages by enhanced production of ROS, TNF-α, MMP-9, and MMP-2. Mol. Cell. Biochem., 2012, 366(1-2), 277-285. doi: 10.1007/s11010-012-1306-y PMID: 22527933
  45. Persson, J.; Nilsson, J.; Lindholm, M.W. Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol., 2008, 9(1), 70. doi: 10.1186/1471-2172-9-70 PMID: 19032770
  46. Jones, C.; Sane, D.C.; Herrington, D.M. Matrix metalloproteinases: A review of their structure and role in acute coronary syndrome. Cardiovasc. Res., 2003, 59(4), 812-823. doi: 10.1016/S0008-6363(03)00516-9 PMID: 14553821
  47. Gough, P.J.; Gomez, I.G.; Wille, P.T.; Raines, E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J. Clin. Invest., 2005, 116(1), 59-69. doi: 10.1172/JCI25074 PMID: 16374516
  48. Stntzing, S.; Heuschmann, P.; Barbera, L.; Ocker, M.; Jung, A.; Kirchner, T.; Neureiter, D. Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis. Ann. Vasc. Surg., 2005, 19(3), 310-319. doi: 10.1007/s10016-005-0003-7 PMID: 15818457
  49. Haro, A.; Saxlin, T.; Suominen, A.L.; Jula, A.; Knuuttila, M.; Ylöstalo, P. Serum lipids modify periodontal infection - interleukin-6 association. J. Clin. Periodontol., 2017, 44(3), 275-282. doi: 10.1111/jcpe.12688 PMID: 28032903
  50. Gonçalves, TO; Costa, D; Brodskyn, CI; Duarte, PM; Neto, JBC; Nogueira-Filho, G Release of cytokines by stimulated peripheral blood mononuclear cells in chronic periodontitis. Arch. Oral. Biol., 2010, 55(12), 975-80. doi: 10.1016/j.archoralbio.2010.08.002. PMID: 20880516
  51. Liu, X.; Wang, Z.; Song, W.; Sun, W.; Hong, R.; Pothukuchi, A.; Xu, Q. Systematically transplanted human gingiva-derived mesenchymal stem cells regulate lipid metabolism and inflammation in hyperlipidemic mice with periodontitis. Exp. Ther. Med., 2020, 19(1), 672-682. PMID: 31885706
  52. Loos, B.G. Systemic effects of periodontitis. Int. J. Dent. Hyg., 2006, 4(s1), 34-38. doi: 10.1111/j.1601-5037.2006.00200.x PMID: 16965532
  53. Paraskevas, S.; Huizinga, J.D.; Loos, B.G. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J. Clin. Periodontol., 2008, 35(4), 277-290. doi: 10.1111/j.1600-051X.2007.01173.x PMID: 18294231
  54. Wang, Z.; Hoy, W.E. C-reactive protein: An independent predictor of cardiovascular disease in Aboriginal Australians. Aust. N. Z. J. Public Health, 2010, 34(Suppl. 1), S25-S29. doi: 10.1111/j.1753-6405.2010.00548.x PMID: 20618287
  55. Wang, T.J.; Larson, M.G.; Levy, D.; Benjamin, E.J.; Kupka, M.J.; Manning, W.J.; Clouse, M.E.; D’Agostino, R.B.; Wilson, P.W.F.; O’Donnell, C.J. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: The framingham heart study. Circulation, 2002, 106(10), 1189-1191. doi: 10.1161/01.CIR.0000032135.98011.C4 PMID: 12208790
  56. Andrukhov, O.; Haririan, H.; Bertl, K.; Rausch, W.D.; Bantleon, H.P.; Moritz, A.; Rausch-Fan, X. Nitric oxide production, systemic inflammation and lipid metabolism in periodontitis patients: Possible gender aspect. J. Clin. Periodontol., 2013, 40(10), 916-923. doi: 10.1111/jcpe.12145 PMID: 23952303
  57. de Maat, M.P.M.; Kluft, C. Determinants of C-reactive protein concentration in blood. BMC News views, 2001, 1(S2), 002. doi: 10.1186/2048-4623-1-S2-002 PMID: 11305530
  58. Leite, A.C.E.; Carneiro, V.M.A.; Guimarães, M.C.M. Effects of periodontal therapy on C-reactive protein and HDL in serum of subjects with periodontitis. Rev. Bras. Cir. Cardiovasc., 2014, 29(1), 69-77. doi: 10.5935/1678-9741.20140013 PMID: 24896165
  59. Almeida, A.P.C.P.S.C.; Fagundes, N.C.F.; Maia, L.C.; Lima, R.R. Is there an association between periodontitis and atherosclerosis in adults? A systematic review. Curr. Vasc. Pharmacol., 2018, 16(6), 569-582. doi: 10.2174/1570161115666170830141852 PMID: 28875830
  60. Iacopino, A.M.; Cutler, C.W. Pathophysiological relationships between periodontitis and systemic disease: Recent concepts involving serum lipids. J. Periodontol., 2000, 71(8), 1375-1384. doi: 10.1902/jop.2000.71.8.1375 PMID: 10972656
  61. Betts, J.C.; Lukey, P.T.; Robb, L.C.; McAdam, R.A.; Duncan, K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol., 2002, 43(3), 717-731. doi: 10.1046/j.1365-2958.2002.02779.x PMID: 11929527
  62. Nonnenmacher, C.; Stelzel, M.; Susin, C.; Sattler, A.M.; Schaefer, J.R.; Maisch, B.; Mutters, R.; Flores-de-Jacoby, L. Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: A case-control study. J. Periodontol., 2007, 78(9), 1724-1730. doi: 10.1902/jop.2007.060345 PMID: 17760542
  63. Ardila, C.M.; Olarte-Sossa, M.; Ariza-Garcés, A.A. Association between the presence of Treponema denticola and reduced levels of antiatherogenic high density lipoprotein in periodontitis. Quintessence Int., 2015, 46(3), 207-215. PMID: 25328922
  64. Aliprantis, A.O.; Yang, R.B.; Mark, M.R.; Suggett, S.; Devaux, B.; Radolf, J.D.; Klimpel, G.R.; Godowski, P.; Zychlinsky, A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science, 1999, 285(5428), 736-739. doi: 10.1126/science.285.5428.736 PMID: 10426996
  65. Okuda, K.; Ishihara, K.; Nakagawa, T.; Hirayama, A.; Inayama, Y.; Okuda, K. Detection of Treponema denticola in atherosclerotic lesions. J. Clin. Microbiol., 2001, 39(3), 1114-1117. doi: 10.1128/JCM.39.3.1114-1117.2001 PMID: 11230436
  66. Ross, R. Atherosclerosis--an inflammatory disease. N. Engl. J. Med., 1999, 340(2), 115-126. doi: 10.1056/NEJM199901143400207 PMID: 9887164
  67. Socransky, S.S.; Haffajee, A.D. The bacterial etiology of destructive periodontal disease: Current concepts. J. Periodontol., 1992, 63(4s), 322-331. doi: 10.1902/jop.1992.63.4s.322
  68. Mysak, J; Podzimek, S; Sommerova, P; Lyuya-Mi, Y; Bartova, J; Janatova, T; Prochazkova, J; Duskova, J Porphyromonas gingivalis: Major periodontopathic pathogen overview. J. Immunol. Res., 2014, 2014, 476068. doi: 10.1155/2014/476068
  69. Lönn, J.; Ljunggren, S.; Klarström-Engström, K.; Demirel, I.; Bengtsson, T.; Karlsson, H. Lipoprotein modifications by gingipains of Porphyromonas gingivalis. J. Periodontal Res., 2018, 53(3), 403-413. doi: 10.1111/jre.12527 PMID: 29341140
  70. Guo, Y.; Nguyen, K.A.; Potempa, J. Dichotomy of gingipains action as virulence factors: From cleaving substrates with the precision of a surgeon’s knife to a meat chopper-like brutal degradation of proteins. Periodontol. 2000, 2010, 54(1), 15-44. doi: 10.1111/j.1600-0757.2010.00377.x PMID: 20712631
  71. Jeong, E.; Kim, K.; Kim, J.H.; Cha, G.S.; Kim, S.J.; Kang, H.S.; Choi, J. Porphyromonas gingivalis HSP60 peptides have distinct roles in the development of atherosclerosis. Mol. Immunol., 2015, 63(2), 489-496. doi: 10.1016/j.molimm.2014.10.004 PMID: 25457882
  72. Kuramitsu, H.K.; Chen, W.; Ikegami, A. Biofilm formation by the periodontopathic bacteria Treponema denticola and Porphyromonas gingivalis. J. Periodontol., 2005, 76(11-s), 2047-2051. doi: 10.1902/jop.2005.76.11-S.2047
  73. Ardila, C.M.; Guzmán, I.C. High levels of Porphyromonas gingivalis -induced immunoglobulin G2 are associated with lower high-density lipoprotein levels in chronic periodontitis. J. Investig. Clin. Dent., 2016, 7(4), 368-375. doi: 10.1111/jicd.12169 PMID: 26074399
  74. Genco, R.; Offenbacher, S.; Beck, J. Periodontal disease and cardiovascular disease. J. Am. Dent. Assoc., 2002, 133(Suppl.), 14S-22S. doi: 10.14219/jada.archive.2002.0375 PMID: 12085720
  75. Champagne, C.; Yoshinari, N.; Oetjen, J.A.; Riché, E.L.; Beck, J.D.; Offenbacher, S. Gender differences in systemic inflammation and atheroma formation following Porphyromonas gingivalis infection in heterozygous apolipoprotein E-deficient mice. J. Periodontal Res., 2009, 44(5), 569-577. doi: 10.1111/j.1600-0765.2008.01156.x PMID: 18973527
  76. Maekawa, T.; Takahashi, N.; Tabeta, K.; Aoki, Y.; Miyashita, H.; Miyauchi, S.; Miyazawa, H.; Nakajima, T.; Yamazaki, K. Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One, 2011, 6(5), e20240. doi: 10.1371/journal.pone.0020240 PMID: 21625524
  77. Frikke-Schmidt, R.; Nordestgaard, B.G.; Stene, M.C.; Sethi, A.A.; Remaley, A.T.; Schnohr, P.; Grande, P.; Tybjaerg-Hansen, A. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA, 2008, 299(21), 2524-2532. doi: 10.1001/jama.299.21.2524 PMID: 18523221
  78. Pussinen, P.J.; Metso, J.; Malle, E.; Barlage, S.; Palosuo, T.; Sattler, W.; Schmitz, G.; Jauhiainen, M. The role of plasma phospholipid transfer protein (PLTP) in HDL remodeling in acute-phase patients. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 2001, 1533(2), 153-163. doi: 10.1016/S1388-1981(01)00153-6 PMID: 11566452
  79. Ly, H.; Francone, O.L.; Fielding, C.J.; Shigenaga, J.K.; Moser, A.H.; Grunfeld, C.; Feingold, K.R. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J. Lipid Res., 1995, 36(6), 1254-1263. doi: 10.1016/S0022-2275(20)41133-2 PMID: 7666003
  80. Bullon, P.; Newman, H.N.; Battino, M. Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: A shared pathology via oxidative stress and mitochondrial dysfunction? Periodontol. 2000, 2014, 64(1), 139-153. doi: 10.1111/j.1600-0757.2012.00455.x PMID: 24320961
  81. Lutfioğlu, M.; Aydoğdu, A.; Atabay, V.E.; Sakallioğlu, E.E.; Avci, B. Gingival crevicular fluid oxidative stress level in patients with periodontal disease and hyperlipidemia. Braz. Oral Res., 2017, 31(0), e110. doi: 10.1590/1807-3107bor-2017.vol31.0110 PMID: 29267671
  82. Krause, S.; Brachmann, P.; Brandes, C.; Lösche, W.; Hoffmann, T.; Gängler, P. Aggregation behaviour of blood granulocytes in patients with periodontal disease. Arch. Oral Biol., 1990, 35(1), 75-77. doi: 10.1016/0003-9969(90)90119-U PMID: 2390026
  83. Le Lay, S.; Simard, G.; Martinez, M.C.; Andriantsitohaina, R. Oxidative stress and metabolic pathologies: From an adipocentric point of view. Oxid. Med. Cell Longev., 2014, 2014, 908539. doi: 10.1155/2014/908539
  84. Chevion, M.; Berenshtein, E.; Stadtman, E.R. Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Radic. Res., 2000, 33, S99-S108. PMID: 11191280
  85. Del Rio, D.; Stewart, A.J.; Pellegrini, N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis., 2005, 15(4), 316-328. doi: 10.1016/j.numecd.2005.05.003 PMID: 16054557
  86. Tsai, C.C.; Chen, H.S.; Chen, S.L.; Ho, Y.P.; Ho, K.Y.; Wu, Y.M.; Hung, C.C. Lipid peroxidation: A possible role in the induction and progression of chronic periodontitis. J. Periodontal Res., 2005, 40(5), 378-384. doi: 10.1111/j.1600-0765.2005.00818.x PMID: 16105090
  87. Griffiths, R.; Barbour, S. Lipoproteins and lipoprotein metabolism in periodontal disease. Clin. Lipidol., 2010, 5(3), 397-411. doi: 10.2217/clp.10.27 PMID: 20835400
  88. Rosenson, R, Jr; Brewer, H; Ansell, B; Barter, P; Chapman, M; Heinecke, J. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat. Rev. Cardiol., 2015, 13(1), 48-60. doi: 10.1038/nrcardio.2015.124. PMID: 26323267
  89. Rom, O; Aviram, M. High-density lipoprotein-associated paraoxonase 1: A possible prognostic biomarker for heart failure? Eur. J. Heart Fail, 2017, 19(6), 756-759. doi: 10.1002/ejhf.817. PMID: 28371029
  90. Ljunggren, S.; Bengtsson, T.; Karlsson, H.; Starkhammar Johansson, C.; Palm, E.; Nayeri, F.; Ghafouri, B.; Davies, J.; Svensäter, G.; Lönn, J. Modified lipoproteins in periodontitis: A link to cardiovascular disease? Biosci. Rep., 2019, 39(3), BSR20181665. doi: 10.1042/BSR20181665 PMID: 30842338
  91. Martin-Ventura, J.; Rodrigues-Diez, R.; Martinez-Lopez, D.; Salaices, M.; Blanco-Colio, L.; Briones, A. Oxidative stress in human atherothrombosis: Sources, markers and therapeutic targets. Int. J. Mol. Sci., 2017, 18(11), 2315. doi: 10.3390/ijms18112315 PMID: 29099757
  92. Ramasamy, I. Recent advances in physiological lipoprotein metabolism. Clin. Chem. Lab. Med., 2014, 52(12), 1695-1727. doi: 10.1515/cclm-2013-0358
  93. Shao, B.; Tang, C.; Sinha, A.; Mayer, P.S.; Davenport, G.D.; Brot, N.; Oda, M.N.; Zhao, X.Q.; Heinecke, J.W. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase. Circ. Res., 2014, 114(11), 1733-1742. doi: 10.1161/CIRCRESAHA.114.303454 PMID: 24647144
  94. Grudyanov, A.I.; Tkacheva, O.N.; Avraamova, T.V. Correlation of chronic periodontal disease and cardiovascular disease. Stomatologia, 2017, 96(1), 4-7. doi: 10.17116/stomat20179614-7 PMID: 28317819
  95. Moncada, S.; Palmer, R.M.; Higgs, E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 1991, 43(2), 109-142. PMID: 1852778
  96. Rausch-Fan, X.; Matejka, M. From plaque formation to periodontal disease, is there a role for nitric oxide? Eur. J. Clin. Invest., 2001, 31(10), 833-835. doi: 10.1046/j.1365-2362.2001.00903.x PMID: 11737219
  97. Kendall, H.K.; Marshall, R.I.; Bartold, P.M. Nitric oxide and tissue destruction. Oral Dis., 2001, 7(1), 2-10. doi: 10.1034/j.1601-0825.2001.70102.x PMID: 11354916
  98. Akalin, F.A.; Şengün, D.; Eratalay, K.; Renda, N.; Çağlayan, G. Hydroxyproline and total protein levels in gingiva and gingival crevicular fluid in patients with juvenile, rapidly progressive, and adult periodontitis. J. Periodontol., 1993, 64(5), 323-329. doi: 10.1902/jop.1993.64.5.323 PMID: 8515361
  99. Uğar-Çankal, D.; Ozmeric, N. A multifaceted molecule, nitric oxide in oral and periodontal diseases. Clin. Chim. Acta., 2006, 366(1-2), 90-100. doi: 10.1016/j.cca.2005.10.018 PMID: 16387291
  100. Assmann, G.; Gotto, A.M., Jr HDL cholesterol and protective factors in atherosclerosis. Circulation, 2004, 109(23_suppl_1), III8-III14. doi: 10.1161/01.CIR.0000131512.50667.46 PMID: 15198960
  101. Shiau, H.J.; Reynolds, M.A. Sex differences in destructive periodontal disease: Exploring the biologic basis. J. Periodontol., 2010, 81(11), 1505-1517. doi: 10.1902/jop.2010.100045 PMID: 20594052
  102. Roeters van Lennep, J.; Westerveld, H.T.; Erkelens, D.W.; van der Wall, E.E. Risk factors for coronary heart disease: Implications of gender. Cardiovasc. Res., 2002, 53(3), 538-549. doi: 10.1016/S0008-6363(01)00388-1 PMID: 11861024
  103. Francis, G.A. High density lipoprotein oxidation: In vitro susceptibility and potential in vivo consequences. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 2000, 1483(2), 217-235. doi: 10.1016/S1388-1981(99)00181-X PMID: 10634938
  104. Barter, P.J.; Baker, P.W.; Rye, K.A. Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr. Opin. Lipidol., 2002, 13(3), 285-288. doi: 10.1097/00041433-200206000-00008 PMID: 12045398
  105. Ren, J.; Jin, W.; Chen, H. oxHDL decreases the expression of CD36 on human macrophages through PPARγ and p38 MAP kinase dependent mechanisms. Mol. Cell. Biochem., 2010, 342(1-2), 171-181. doi: 10.1007/s11010-010-0481-y PMID: 20458524
  106. Nakajima, T.; Origuchi, N.; Matsunaga, T.; Kawai, S.; Hokari, S.; Nakamura, H.; Inoue, I.; Katayama, S.; Nagata, A.; Komoda, T. Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann. Clin. Biochem., 2000, 37(2), 179-186. doi: 10.1258/0004563001899186 PMID: 10735361
  107. Guengerich, F.P. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol., 2001, 14(6), 611-650. doi: 10.1021/tx0002583 PMID: 11409933
  108. Elbekai, R.H.; El-Kadi, A.O.S. Cytochrome P450 enzymes: Central players in cardiovascular health and disease. Pharmacol. Ther., 2006, 112(2), 564-587. doi: 10.1016/j.pharmthera.2005.05.011 PMID: 16824612
  109. Sugawara, T.; Nomura, E.; Sagawa, T.; Sakuragi, N.; Fujimoto, S. CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int. J. Gynecol. Cancer, 2003, 13(6), 785-790. doi: 10.1136/ijgc-00009577-200311000-00009 PMID: 14675315
  110. Shah, P.P.; Saurabh, K.; Pant, M.C.; Mathur, N.; Parmar, D. Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients. Mutat. Res., 2009, 670(1-2), 74-78. doi: 10.1016/j.mrfmmm.2009.07.006 PMID: 19632247
  111. Zou, J.G.; Ma, Y.T.; Xie, X.; Yang, Y.N.; Pan, S.; Adi, D.; Liu, F.; Chen, B.D. The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China. Lipids Health Dis., 2014, 13(1), 2. doi: 10.1186/1476-511X-13-145 PMID: 25189712
  112. Wang, X.; Li, W.; Song, W.; Xu, L.; Zhang, L.; Feng, X.; Lu, R.; Meng, H. Association ofCYP 1A1 rs1048943 variant with aggressive periodontitis and its interaction with hyperlipidemia on the periodontal status. J. Periodontal Res., 2019, 54(5), 546-554. doi: 10.1111/jre.12658 PMID: 31032950
  113. Linden, G.J.; Herzberg, M.C. Periodontitis and systemic diseases: A record of discussions of working group 4 of the joint EFP/AAP workshop on periodontitis and systemic diseases. J. Periodontol., 2013, 84(4), S20-S23. PMID: 23631580
  114. Napoli, N.; Villareal, D.T.; Mumm, S.; Halstead, L.; Sheikh, S.; Cagaanan, M.; Rini, G.B.; Armamento-Villareal, R. Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J. Bone Miner. Res., 2005, 20(2), 232-239. doi: 10.1359/JBMR.041110 PMID: 15647817
  115. Jarrar, Y.B.; Cho, S.A.; Oh, K.S.; Kim, D.H.; Shin, J.G.; Lee, S.J. Identification of cytochrome P450s involved in the metabolism of arachidonic acid in human platelets. Prostaglandins Leukot. Essent. Fatty Acids, 2013, 89(4), 227-234. doi: 10.1016/j.plefa.2013.06.008 PMID: 23932368
  116. Nibali, L.; Pelekos, G.; D’Aiuto, F.; Chaudhary, N.; Habeeb, R.; Ready, D.; Parkar, M.; Donos, N. Influence of IL-6 haplotypes on clinical and inflammatory response in aggressive periodontitis. Clin. Oral Investig., 2013, 17(4), 1235-1242. PMID: 22918663
  117. Nibali, L.; Rizzo, M.; Li Volti, G.; D’Aiuto, F.; Giglio, R.V.; Barbagallo, I.; Pelekos, G.; Donos, N. Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment. J. Periodontal Res., 2015, 50(6), 890-896. doi: 10.1111/jre.12283 PMID: 25994389
  118. Hassan, W.; Ding, L.; Gao, R.Y.; Liu, J.; Shang, J. Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders. Cytokine, 2014, 66(2), 133-142. doi: 10.1016/j.cyto.2013.12.017 PMID: 24491813
  119. Fu, Y.W.; Li, X.X.; Xu, H.Z.; Gong, Y.Q.; Yang, Y. Effects of periodontal therapy on serum lipid profile and proinflammatory cytokines in patients with hyperlipidemia: A randomized controlled trial. Clin. Oral Investig., 2016, 20(6), 1263-1269. doi: 10.1007/s00784-015-1621-2 PMID: 26434651
  120. Kudo, C.; Shin, W.S.; Sasaki, N.; Harai, K.; Kato, K.; Seino, H.; Goke, E.; Fujino, T.; Kuribayashi, N.; Pearce, Y.O.; Taira, M.; Matsushima, R.; Minabe, M.; Takashiba, S. Effects of periodontal treatment on carotid intima-media thickness in patients with lifestyle-related diseases: Japanese prospective multicentre observational study. Odontology, 2018, 106(3), 316-327. doi: 10.1007/s10266-017-0331-4 PMID: 29330707
  121. Subha, D.S.; Pradeep, T. Periodontal therapy with 0.25%lemongrass oil mouthwash in reducing risk of cardiovascular diseases: A 3-arm prospective parallel experimental study. Ethiop. J. Health Sci., 2017, 27(5), 531-540. doi: 10.4314/ejhs.v27i5.12 PMID: 29217959
  122. Ertugrul, A.S.; Bozoglan, A.; Taspınar, M. The effect of nonsurgical periodontal treatment on serum and gingival crevicular fluid markers in patients with atherosclerosis. Niger. J. Clin. Pract., 2017, 20(3), 361-368. doi: 10.4103/1119-3077.181369 PMID: 28256493
  123. Garde, S.; Akhter, R.; Nguyen, M.A.; Chow, C.K.; Eberhard, J. Periodontal therapy for improving lipid profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Int. J. Mol. Sci., 2019, 20(15), 3826. doi: 10.3390/ijms20153826 PMID: 31387283
  124. Teeuw, W.J.; Slot, D.E.; Susanto, H.; Gerdes, V.E.A.; Abbas, F.; D’Aiuto, F.; Kastelein, J.J.P.; Loos, B.G. Treatment of periodontitis improves the atherosclerotic profile: A systematic review and meta-analysis. J. Clin. Periodontol., 2014, 41(1), 70-79. doi: 10.1111/jcpe.12171 PMID: 24111886
  125. Tawfig, A. Effects of non-surgical periodontal therapy on serum lipids and C-reactive protein among hyperlipidemic patients with chronic periodontitis. J. Int. Soc. Prev. Community Dent., 2015, 5(7 (S1) ), 49. doi: 10.4103/2231-0762.156524 PMID: 25984468
  126. de Fatima Pedroso, J.; Lotfollahi, Z.; Albattarni, G.; Schulz, M.A.; Monteiro, A.; Sehnem, A.L. Influence of periodontal disease on cardiovascular markers in Diabetes Mellitus patients. Sci. Rep., 2019, 9(1), 1-9. PMID: 30626917
  127. Li, L.; Messas, E.; Batista, E.L., Jr; Levine, R.A.; Amar, S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation, 2002, 105(7), 861-867. doi: 10.1161/hc0702.104178 PMID: 11854128
  128. Maglakelidze, N.; Galogre, A.; Tsagareli, Z. Functional-morphologic aspects of changes of mucosal gingiva microcirculatory bed vessels in experimental gingivitis against the background of hypercholesterolemia. Georgian Med. News, 2005, (121), 71-74. PMID: 15908731
  129. Buhlin, K.; Gustafsson, A.; Pockley, A.G.; Frostegård, J.; Klinge, B. Risk factors for cardiovascular disease in patients with periodontitis. Eur. Heart J., 2003, 24(23), 2099-2107. doi: 10.1016/j.ehj.2003.09.016 PMID: 14643270
  130. Seijkens, T.; Hoeksema, M.A.; Beckers, L.; Smeets, E.; Meiler, S.; Levels, J.; Tjwa, M.; Winther, M.P.J.; Lutgens, E. Hypercholesterolemia-induced priming of hematopoietic stem and progenitor cells aggravates atherosclerosis. FASEB J., 2014, 28(5), 2202-2213. doi: 10.1096/fj.13-243105 PMID: 24481967
  131. Fentoğlu, Ö.; Kırzıoğlu, F.Y.; Bulut, M.T.; Kumbul Doğuç, D.; Kulaç, E.; Önder, C.; Günhan, M. Evaluation of lipid peroxidation and oxidative DNA damage in patients with periodontitis and hyperlipidemia. J. Periodontol., 2015, 86(5), 682-688. doi: 10.1902/jop.2015.140561 PMID: 25612631
  132. Rufail, M.L.; Schenkein, H.A.; Barbour, S.E.; Tew, J.G.; van Antwerpen, R. Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis. J. Lipid Res., 2005, 46(12), 2752-2760. doi: 10.1194/jlr.M500389-JLR200 PMID: 16179738
  133. Borilova Linhartova, P.; Bartova, J.; Poskerova, H.; Machal, J.; Vokurka, J.; Fassmann, A.; Izakovicova Holla, L. Apolipoprotein E gene polymorphisms in relation to chronic periodontitis, periodontopathic bacteria, and lipid levels. Arch. Oral Biol., 2015, 60(3), 456-462. doi: 10.1016/j.archoralbio.2014.10.003 PMID: 25545672
  134. Lee, S.; Im, A.; Burm, E.; Ha, M. Association between periodontitis and blood lipid levels in a Korean population. J. Periodontol., 2018, 89(1), 28-35. PMID: 28871890
  135. Boyapati, R.; Chinthalapani, S.; Ramisetti, A.; Salavadhi, S.; Ramachandran, R. Association of pentraxin and high-sensitive C-reactive protein as inflammatory biomarkers in patients with chronic periodontitis and peripheral arterial disease. J. Indian Soc. Periodontol., 2018, 22(2), 112-115. doi: 10.4103/jisp.jisp_290_17 PMID: 29769764
  136. Sayar, F.; Fallah, S.; Akhondi, N.; Jamshidi, S. Association of serum lipid indices and statin consumption with periodontal status. Oral Dis., 2016, 22(8), 775-780. doi: 10.1111/odi.12545 PMID: 27426870
  137. Górski, B.; Nargiełło, E.; Opolski, G.; Ganowicz, E.; Górska, R. The association between dental status and systemic lipid profile and inflammatory mediators in patients after myocardial infarction. Adv. Clin. Exp. Med., 2016, 25(4), 625-632. doi: 10.17219/acem/62937 PMID: 27629835
  138. Koshy, B.S.; Mahendra, J. The association between periodontal status, serum lipid levels, lipoprotein associated phosholipase A2 (Lp-PLA2) in chronic periodontitis subjects and healthy controls. J. Clin. Diagn. Res., 2017, 11(9), ZC17-ZC21. doi: 10.7860/JCDR/2017/27628.10565 PMID: 29207826
  139. Macri, E.; Lifshitz, F.; Ramos, C.; Orzuza, R.; Costa, O.; Zago, V.; Boyer, P.; Friedman, S. Atherogenic cholesterol-rich diet and periodontal disease. Arch. Oral Biol., 2014, 59(7), 679-686. doi: 10.1016/j.archoralbio.2014.03.006 PMID: 24769219
  140. Nepomuceno, R.; Pigossi, S.C.; Finoti, L.S.; Orrico, S.R.P.; Cirelli, J.A.; Barros, S.P.; Offenbacher, S.; Scarel-Caminaga, R.M. Serum lipid levels in patients with periodontal disease: A meta-analysis and meta-regression. J. Clin. Periodontol., 2017, 44(12), 1192-1207. doi: 10.1111/jcpe.12792 PMID: 28782128

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers